Veery Capital LLC Purchases Shares of 6,000 Semler Scientific, Inc. (NASDAQ:SMLR)

Veery Capital LLC acquired a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 6,000 shares of the company’s stock, valued at approximately $324,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in SMLR. Bank of New York Mellon Corp lifted its stake in shares of Semler Scientific by 10.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock valued at $709,000 after purchasing an additional 1,940 shares during the period. Rhumbline Advisers increased its holdings in Semler Scientific by 27.1% in the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock valued at $213,000 after buying an additional 1,320 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Semler Scientific by 18.3% in the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after acquiring an additional 19,552 shares during the period. AQR Capital Management LLC boosted its stake in shares of Semler Scientific by 150.1% during the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after acquiring an additional 84,314 shares in the last quarter. Finally, Newbridge Financial Services Group Inc. acquired a new stake in shares of Semler Scientific during the 2nd quarter valued at about $34,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Up 11.1 %

Shares of Semler Scientific stock opened at $64.68 on Friday. The firm has a market cap of $599.58 million, a PE ratio of 31.55 and a beta of 1.18. Semler Scientific, Inc. has a twelve month low of $20.88 and a twelve month high of $81.56. The business has a 50-day moving average price of $59.12 and a 200 day moving average price of $39.32.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The business had revenue of $13.51 million during the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.